CCA Industries, Inc. Announces Sale of Lobe Miracle Brand

Rhea-AI Summary

CCA Industries (OTCID:CAWW) sold its Lobe Miracle brand to Kingsway Pharmaceuticals effective January 29, 2026 for $1,200,000 plus inventory at cost estimated at $217,886, and transferred associated intellectual property.

CCA will use proceeds to reduce accounts payable and for working capital, maintain its available line of credit, and reallocate focus toward expanding Plus White and other core brands.

Positive

• Sale of Lobe Miracle for $1,200,000 plus $217,886 inventory at cost
• Proceeds allocated to pay down accounts payable and working capital
• Company retains its available line of credit

Negative

• Disposition reduces CCA's brand portfolio and associated future revenues
• Company cited a prior debt burden that limited investment capacity

News Market Reaction

+20.00%

1 alert

+20.00% News Effect

On the day this news was published, CAWW gained 20.00%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

FORT WASHINGTON, PA / ACCESS Newswire / February 4, 2026 / CCA Industries, Inc. (OTCID:CAWW) has sold its Lobe Miracle brand to Kingsway Pharmaceuticals, LLC effective January 29, 2026. The brand was sold for $1,200,000 plus inventory at cost for an estimated $217,886 and includes all intellectual property pertaining to the Lobe Miracle brand. The Company will be using the proceeds to pay down outstanding accounts payable and the balance to be used for working capital purposes. The Company plans on maintaining the available line of credit. Christopher Dominello, the company's Chief Executive Officer commented, "This transaction positions CCA to accelerate the growth of our brands, with Plus White as a primary focus, within our portfolio. Over the past few years, we've made significant progress in streamlining operations, including relocating our third-party warehouse to Kansas City, which has reduced both warehousing and freight costs. While these improvements have strengthened our foundation, past losses had left us with a debt burden that limited our ability to invest in growth."

Dominello continued, "With this strategic realignment, CCA now has the financial flexibility to prioritize initiatives that drive topline growth across our portfolio. Allowing us to invest strategically in advertising and to deliver innovative products to our customers. We are excited to embark on this new chapter, with a primary focus on expanding Plus White while also driving growth and value across all our brands."

About CCA Industries Inc.

CCA Industries, Inc. manufactures and markets health and beauty aids, each under its individual brand name. The products include, principally, "Plus White" toothpastes and teeth whiteners, "Nutra Nail" nail care treatments, "Porcelana" skin care products, "Scar Zone" scar treatment products, "Sudden Change" anti-aging skin care products, "Hair Off" depilatory products, and "Neutein" brain health supplements.

Company Contact:
Stephen A. Heit
201-935-3232, Extension 183

SOURCE: CCA Industries, Inc.

View the original press release on ACCESS Newswire

FAQ

What were the terms of CCA Industries (CAWW) sale of Lobe Miracle?

CCA sold Lobe Miracle to Kingsway Pharmaceuticals effective Jan 29, 2026 for $1,200,000 plus inventory at cost estimated at $217,886. According to CCA Industries, the sale included all intellectual property for the Lobe Miracle brand.

How will the Lobe Miracle sale affect CCA Industries (CAWW) finances?

Proceeds will be used to reduce accounts payable and provide working capital. According to CCA Industries, the company plans to apply the cash to pay down outstanding payables and strengthen short-term liquidity.

What does the sale mean for CCA's focus on Plus White (CAWW)?

CCA will prioritize expanding Plus White and core brands after the sale. According to CCA Industries, the transaction is intended to accelerate growth investments, including advertising and product development for Plus White.

Will CCA Industries (CAWW) keep its line of credit after the sale?

Yes, CCA plans to maintain its available line of credit while using sale proceeds for payables and working capital. According to CCA Industries, the company intends to preserve borrowing capacity for operational flexibility.

Did the Lobe Miracle sale include intellectual property and inventory for CAWW?

Yes; the sale transferred the brand's intellectual property and inventory at cost. According to CCA Industries, the transaction explicitly included all intellectual property relating to Lobe Miracle and inventory valued at an estimated $217,886.